Methods of preventing or treating filovirus and flavivirus diseases
US10987371B2 · kind B2 · utility
0Cited by
4References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 7, 2018 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | Jun 7, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing the risk of filovirus hemorrhagic fever or a symptom thereof in a mammal host exposed to a filovirus (e.g., Ebola or Zika virus), comprising administering an effective amount of quercetin-3 β-O-D-glucoside (Q3G) or an analogue thereof, or a composition comprising Q3G or analogue thereof and a pharmaceutically acceptable carrier, to said host prior to said exposure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.